| UniProt ID | CLPB_HUMAN | |
|---|---|---|
| UniProt AC | Q9H078 | |
| Protein Name | Caseinolytic peptidase B protein homolog | |
| Gene Name | CLPB | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 707 | |
| Subcellular Localization | Mitochondrion . | |
| Protein Description | May function as a regulatory ATPase and be related to secretion/protein trafficking process.. | |
| Protein Sequence | MLGSLVLRRKALAPRLLLRLLRSPTLRGHGGASGRNVTTGSLGEPQWLRVATGGRPGTSPALFSGRGAATGGRQGGRFDTKCLAAATWGRLPGPEETLPGQDSWNGVPSRAGLGMCALAAALVVHCYSKSPSNKDAALLEAARANNMQEVSRLLSEGADVNAKHRLGWTALMVAAINRNNSVVQVLLAAGADPNLGDDFSSVYKTAKEQGIHSLEDGGQDGASRHITNQWTSALEFRRWLGLPAGVLITREDDFNNRLNNRASFKGCTALHYAVLADDYRTVKELLDGGANPLQRNEMGHTPLDYAREGEVMKLLRTSEAKYQEKQRKREAEERRRFPLEQRLKEHIIGQESAIATVGAAIRRKENGWYDEEHPLVFLFLGSSGIGKTELAKQTAKYMHKDAKKGFIRLDMSEFQERHEVAKFIGSPPGYVGHEEGGQLTKKLKQCPNAVVLFDEVDKAHPDVLTIMLQLFDEGRLTDGKGKTIDCKDAIFIMTSNVASDEIAQHALQLRQEALEMSRNRIAENLGDVQISDKITISKNFKENVIRPILKAHFRRDEFLGRINEIVYFLPFCHSELIQLVNKELNFWAKRAKQRHNITLLWDREVADVLVDGYNVHYGARSIKHEVERRVVNQLAAAYEQDLLPGGCTLRITVEDSDKQLLKSPELPSPQAEKRLPKLRLEIIDKDSKTRRLDIRAPLHPEKVCNTI | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 23 | Phosphorylation | LLLRLLRSPTLRGHG HHHHHHCCCCCCCCC | 23.39 | 22167270 | |
| 25 | Phosphorylation | LRLLRSPTLRGHGGA HHHHCCCCCCCCCCC | 30.27 | 22167270 | |
| 38 | Phosphorylation | GASGRNVTTGSLGEP CCCCCCCCCCCCCCC | 29.05 | - | |
| 41 | Phosphorylation | GRNVTTGSLGEPQWL CCCCCCCCCCCCEEE | 30.98 | - | |
| 58 | Phosphorylation | ATGGRPGTSPALFSG ECCCCCCCCCCHHCC | 33.93 | 25394399 | |
| 64 | Phosphorylation | GTSPALFSGRGAATG CCCCCHHCCCCCCCC | 28.56 | 24719451 | |
| 112 | Ubiquitination | NGVPSRAGLGMCALA CCCCCCHHHHHHHHH | 22.96 | - | |
| 134 | Ubiquitination | YSKSPSNKDAALLEA HCCCCCCHHHHHHHH | 53.75 | - | |
| 163 (in isoform 2) | Ubiquitination | - | 24.85 | - | |
| 163 | Ubiquitination | EGADVNAKHRLGWTA CCCCCCHHHHHHHHH | 24.85 | - | |
| 240 | Ubiquitination | ALEFRRWLGLPAGVL HHHHHHHHCCCCEEE | 4.85 | - | |
| 263 | Phosphorylation | NRLNNRASFKGCTAL CCCCCCCCCCCCCHH | 25.01 | 24719451 | |
| 283 (in isoform 2) | Ubiquitination | - | 41.87 | - | |
| 298 | Sulfoxidation | NPLQRNEMGHTPLDY CCCCCCCCCCCCCCH | 5.64 | 28183972 | |
| 313 | Ubiquitination | AREGEVMKLLRTSEA HHHHHHHHHHHHHHH | 49.93 | - | |
| 313 | Acetylation | AREGEVMKLLRTSEA HHHHHHHHHHHHHHH | 49.93 | 25953088 | |
| 321 | Acetylation | LLRTSEAKYQEKQRK HHHHHHHHHHHHHHH | 43.33 | 26051181 | |
| 322 | Phosphorylation | LRTSEAKYQEKQRKR HHHHHHHHHHHHHHH | 29.02 | 24275569 | |
| 388 | Ubiquitination | GSSGIGKTELAKQTA CCCCCCHHHHHHHHH | 30.90 | - | |
| 392 | Acetylation | IGKTELAKQTAKYMH CCHHHHHHHHHHHHC | 61.89 | 25953088 | |
| 411 (in isoform 2) | Ubiquitination | - | 4.97 | - | |
| 412 (in isoform 2) | Ubiquitination | - | 34.62 | - | |
| 426 | Phosphorylation | EVAKFIGSPPGYVGH HHHHHHCCCCCCCCC | 24.09 | 25159151 | |
| 441 | 2-Hydroxyisobutyrylation | EEGGQLTKKLKQCPN CHHCHHHHHHHHCCC | 65.78 | - | |
| 441 | Malonylation | EEGGQLTKKLKQCPN CHHCHHHHHHHHCCC | 65.78 | 26320211 | |
| 441 | Ubiquitination | EEGGQLTKKLKQCPN CHHCHHHHHHHHCCC | 65.78 | - | |
| 530 | Acetylation | ENLGDVQISDKITIS HHHCCCCCCCCEEEC | 6.05 | 19608861 | |
| 538 | Acetylation | SDKITISKNFKENVI CCCEEECCCHHHHCH | 63.65 | 25953088 | |
| 538 | Ubiquitination | SDKITISKNFKENVI CCCEEECCCHHHHCH | 63.65 | - | |
| 541 | Acetylation | ITISKNFKENVIRPI EEECCCHHHHCHHHH | 58.74 | 25953088 | |
| 544 | Acetylation | SKNFKENVIRPILKA CCCHHHHCHHHHHHH | 4.05 | 19608861 | |
| 559 | Acetylation | HFRRDEFLGRINEIV HHCHHHHHHHHHHHH | 4.19 | 19608861 | |
| 559 (in isoform 2) | Ubiquitination | - | 4.19 | - | |
| 589 | Acetylation | KELNFWAKRAKQRHN HHHHHHHHHHHHHCC | 43.41 | 19608861 | |
| 589 | Ubiquitination | KELNFWAKRAKQRHN HHHHHHHHHHHHHCC | 43.41 | 19608861 | |
| 652 | Phosphorylation | GGCTLRITVEDSDKQ CCCEEEEEEECHHHH | 16.06 | 20068231 | |
| 656 | Phosphorylation | LRITVEDSDKQLLKS EEEEEECHHHHHHCC | 32.95 | 20068231 | |
| 658 | Acetylation | ITVEDSDKQLLKSPE EEEECHHHHHHCCCC | 46.96 | 27452117 | |
| 663 | Phosphorylation | SDKQLLKSPELPSPQ HHHHHHCCCCCCCHH | 24.47 | 25159151 | |
| 668 | Phosphorylation | LKSPELPSPQAEKRL HCCCCCCCHHHHHHC | 42.12 | 21815630 | |
| 673 | 2-Hydroxyisobutyrylation | LPSPQAEKRLPKLRL CCCHHHHHHCCCCCE | 63.35 | - | |
| 673 | Ubiquitination | LPSPQAEKRLPKLRL CCCHHHHHHCCCCCE | 63.35 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CLPB_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CLPB_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CLPB_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| MDFI_HUMAN | MDFI | physical | 19060904 | |
| ERC6L_HUMAN | ERCC6L | physical | 26186194 | |
| SEN2_HUMAN | TSEN2 | physical | 26186194 | |
| OGA_HUMAN | MGEA5 | physical | 26186194 | |
| TTF2_HUMAN | TTF2 | physical | 26186194 | |
| CLU_HUMAN | CLUH | physical | 28514442 | |
| P33MX_HUMAN | KIAA1191 | physical | 28514442 | |
| PHAG1_HUMAN | PAG1 | physical | 28514442 | |
| ARFP1_HUMAN | ARFIP1 | physical | 28514442 | |
| SETB1_HUMAN | SETDB1 | physical | 28514442 | |
| TRI11_HUMAN | TRIM11 | physical | 28514442 | |
| IF2M_HUMAN | MTIF2 | physical | 28514442 | |
| MDM2_HUMAN | MDM2 | physical | 28514442 | |
| GTPBA_HUMAN | GTPBP10 | physical | 28514442 | |
| EXOG_HUMAN | EXOG | physical | 28514442 | |
| IF5_HUMAN | EIF5 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 616271 | 3-methylglutaconic aciduria with cataracts, neurologic involvement and neutropenia (MEGCANN) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-589, AND MASS SPECTROMETRY. | |